Regulatory Strategy

Our regulatory affairs team has established firm relationships with the regulatory agencies in the UK, US and EU. The company’s longevity and involvement in many innovative projects over the last 25+ years have served to build an unrivalled body of experience that can be deployed in helping you engage in informed and productive discussions with regulatory agencies.

We are eager to provide the regulatory affairs support you need to facilitate the fast and efficient development of your innovative medicines. Integrating with your scientific leaders, the Niche team is highly flexible and can adapt to your needs, whether that involves us playing a lead role or simply assisting via the provision of thoughtful and well-considered strategic input.


"Niche provided invaluable support and their flexibility and ingenuity helped my team overcome many obstacles."
Chaman Chandler
Research Manager
Baxter Healthcare

Our team are eager to help you with the regulatory affairs support you need to facilitate the fast and efficient development of your innovative medicines. Comfortable integrating with your scientific leaders, the Niche team is highly flexible and can adapt to your needs, whether that involves us playing a lead regulatory role or simply assisting your existing regulatory team via the provision of thoughtful and well-considered strategic input.

 

In addition to supporting your cutting-edge and advanced therapies along their regulatory journey, the Niche team have access to the necessary resources to assist with the preparation of regulatory documentation in a timely fashion, guiding you past the various milestones that mark your product’s journey from the laboratory to the market.

 

Regulatory process support, including:

  • Regulatory strategy
  • Due diligence and gap analysis
  • Regulatory strategy for paediatric development
  • Lifecycle management (EMA, MHRA, FDA)

 

Development of clinical/non-clinical regulatory submissions:

  • CMC, non-clinical and clinical expertise
  • Clinical trial applications (EMA, MHRA, FDA)
  • Orphan drug applications (EMA, MHRA, FDA)
  • Scientific advice (EMA, MHRA, FDA)
  • Marketing authorization applications (EMA, MHRA, FDA)
  • Innovative Licensing and Access Pathway (UK) and PRIME (EMA) submissions

Download our services guide 
Frequently Asked Questions
We routinely participate in client leadership meetings to develop tailored regulatory strategies. 

Our approach takes into account all aspects of clinical development, including the asset’s mode of action and patient population, as well as overall business objectives.
We have extensive regulatory experience in the United States, United Kingdom, and the European Union, and we are well-versed in regulatory requirements worldwide.
We always have the time to discuss your challenges before creating adapted solutions to help you achieve your goals.
We aim to integrate into your team, ready to provide support as and when you need us. In addition to scheduled meetings and delivery milestones, our team are always happy to take part in a call to discuss any acute challenges or concerns.
Niche has built its industry reputation on transparency, competitive pricing and cost-efficient delivery models.

Case Histories

Industry news and comment

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility
chevron-down